- Home
- BIO vs DOO Comparison
BIO vs DOO Comparison
Compare BIO & DOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIO | DOO |
|---|---|---|
| Founded | 1952 | 1937 |
| Country | United States | Canada |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BIO | DOO |
|---|---|---|
| Price | $277.40 | $75.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $339.75 | $80.50 |
| AVG Volume (30 Days) | ★ 282.4K | 219.7K |
| Earning Date | 04-30-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.59 | $7.62 |
| Revenue Next Year | $3.21 | $5.54 |
| P/E Ratio | ★ $9.72 | $338.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $60.02 |
| 52 Week High | $343.12 | $81.89 |
Technical Indicators
Market Signals| Indicator | BIO | DOO |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 64.74 |
| Support Level | $256.85 | $75.22 |
| Resistance Level | $289.61 | $81.52 |
| Average True Range (ATR) | 7.87 | 2.93 |
| MACD | 1.42 | 1.36 |
| Stochastic Oscillator | 61.26 | 88.89 |
Price Performance
Historical ComparisonAbout BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.